| Catalog | name | Description | price |
|---|---|---|---|
| R-R-4617 | RG7800 CAS No.1449598-06-4 | RG7800/CAS No.1449598-06-4 is a SMN2 splicing modifier. RG7800 has the potential for spinal muscular atrophy treatment. | price> |
| R-R-4618 | DHX9-IN-2 CAS No.2973395-71-8 | DHX9-IN-2 (example 31)/CAS No.2973395-71-8 is an inhibitor of ATP-dependent RNA helicase A (DHX9), with the IC50 of 0.0698 nM that has antitumor activity. | price> |
| R-R-4619 | JH-RE-06 CAS No.1361227-90-8 | JH-RE-06/CAS No.1361227-90-8, a potent REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing recruitment of mutagenic POLζ. JH-RE-06 improves chemotherapy. | price> |
| R-R-4620 | Zoliflodacin CAS No.1620458-09-4 | Zoliflodacin (ETX0914;AZD0914)/CAS No.1620458-09-4 is a novel spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor. Zoliflodacin has potent in vitro antibacterial activity against Gram-positive and Gram-negative organisms, including S. aureus with the MIC90 of 0.25 μg/mL. | price> |
| R-R-4621 | 116-9e CAS No.831217-43-7 | 116-9e (MAL2-11B)/CAS No.831217-43-7 is a Hsp70 co-chaperone DNAJA1 inhibitor. 116-9e inhibits Simian Virus 40 (SV40) replication and DNA synthesis. | price> |
| R-R-4622 | DDD85646 CAS No.1215010-55-1 | DDD85646 (IMP-366)/CAS No.1215010-55-1 is an orally active of trypanosoma brucei N-myristoyltransferase (TbNMT IC50=2 nM; hNMT IC50=4 nM). The enzyme N-myristoyltransferase (NMT) is a potential agent target for human African trypanosomiasis. | price> |
| R-R-4623 | Fialuridine CAS No.69123-98-4 | Fialuridine/CAS No.69123-98-4 is a nucleoside analog with antiviral activity. Fialuridine shows anti-orthopoxvirus activity. | price> |
| R-R-4624 | L82 CAS No.329227-30-7 | L82/CAS No.329227-30-7 is a selective and uncompetitive DNA ligase 1 (DNA Lig1) inhibitor (hLig1 IC50=12 μM). L82 shows anti-proliferative activity to breast cancer cells | price> |
| R-R-4625 | COH29 CAS No.1190932-38-7 | COH29 (RNR Inhibitor COH29)/CAS No.1190932-38-7 is a potent ribonucleotide reductase (RNR) inhibitor with anticancer activity. COH29 inhibits α and β subunit of RNR with IC50s of 16 μM. | price> |
| R-R-4626 | L189 CAS No.64232-83-3 | L189/CAS No.64232-83-3 is a DNA ligase inhibitor. L189 has inhibition effect for DNA Ligase I, III and IV with IC50 values of 5 μM, 9 μM and 5 μM, respectively. L189 has no cytotoxicity and individually increase cell death. L189 can be used for the research of cancer. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


